FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090544 [Registered on: 09/07/2025] Trial Registered Prospectively
Last Modified On: 08/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Evolving Homoeopathic Approaches in ADHD: A Clinical Case-Based Study 
Scientific Title of Study   Evolving the therapeutics in the treatment of attention deficit hyperactivity disorder through clinical cases – An experimental uncontrolled study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jairaj Mahaveer Patil 
Designation  Professor and PG Guide 
Affiliation  Bharatesh Homoeopathic Medical College and Hospital 
Address  Dept. Of Homoeopathic Materia Medica, First floor, Bharatesh Homoeopathic Medical College and Hospital, Sy. No 16, Basavan Kudachi Extension, Shindoli Road, Belagavi

Belgaum
KARNATAKA
591124
India 
Phone  9916864400  
Fax    
Email  drjairajmpatilmd@gmail.com   
 
Details of Contact Person
Scientific Query
 
Name  Dr Moreshwar R Kulkarni 
Designation  Professor and PG Guide 
Affiliation  SJPEs Homoeopathic Medical College and Hospital 
Address  Dept. Of Homoeopathic Materia Medica, Ground Floor, SJPEs Homoeopathic Medical College and Hospital, 200, E, Tararani Chowk,

Kolhapur
MAHARASHTRA
416003
India 
Phone  9850839483  
Fax    
Email  mrkulkarni242@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jairaj Mahaveer Patil 
Designation  Professor and PG Guide 
Affiliation  Bharatesh Homoeopathic Medical College and Hospital 
Address  Dept. Of Homoeopathic Materia Medica, First floor, Bharatesh Homoeopathic Medical College and Hospital, Sy. No 16, Basavan Kudachi Extension, Shindoli Road, Belagavi

Belgaum
KARNATAKA
591124
India 
Phone  9916864400  
Fax    
Email  drjairajmpatilmd@gmail.com   
 
Source of Monetary or Material Support  
Bharatesh Homoeopathic Medical College and Hospital, Sy. No-16, Basavan Kudachi Extension, Shindoli Road, Belagavi, Pin-591124, Karnataka, India 
 
Primary Sponsor  
Name  Dr Jairaj Mahaveer Patil 
Address  Dept. Of Homoeopathic Materia Medica, First floor, Bharatesh Homoeopathic Medical College and Hospital, Sy. No-16, Basavan Kudachi Extension, Shindoli Road, Belagavi, Pin-591124, Karnataka, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jairaj Mahaveer Patil  Bharatesh Homoeopathic Medical College and Hospital,  Dept. of Medicine, OPD No-04, Ground Floor, Sy. No-16, Basavan Kudachi Extension, Shindoli Road, Belagavi, Karnataka, India- 591124
Belgaum
KARNATAKA 
9916864400

drjairajmpatilmd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F90||Attention-deficit hyperactivity disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homeopathic Remedy  1) Individualized Homeopathic Remedy, Route: Oral, Dose: 4 globules stat. 2) Non-Medicated globules, Route: Oral, Dose: 4 globules/BD/Day/ Month for a Duration of 6 months.  
Comparator Agent  Not Applicable   Not Applicable  
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  15.00 Year(s)
Gender  Both 
Details  1) Subjects of both sexes between the age group of 5 to 15 years irrespective of their socioeconomic status shall be included under the subjects assent and parent’s informed consent.

2) All three types (Predominately hyperactive-impulsive, predominately inattentive, combined hyperactive-impulsive and inattentive) of ADHD subjects clinically diagnosed cases as per Diagnostic Statistical Manual of Mental Disorder-V (DSM-V) shall be considered for the study.

3) Subjects with baseline score equal or greater than 37 on Vanderbilt ADHD diagnostic parent rating scale (VADPRS) shall be included. 
 
ExclusionCriteria 
Details  1) Subjects with Intellectual disability (Mental retardation).

2) Subjects with other mental disorders, OCD, Schizophrenia.

3) Subjects having history of any medical illness like hypothyroidism, genetic disorder and neurological disorders.

4) Subjects having congenital deformity.

5) Subjects who are on any other medications for known chronic illness like allergic conditions, systemic illness, failures of vital organs or systems as detected clinically.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Outcome will be assessed as the change in the pre and post intervention scores as assessed using the Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) over a period of 6 months  Outcome will be assessed/estimated at baseline, and subsequently on a monthly basis for a duration of 6 months. 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This paper presents an experimental uncontrolled study aimed at evolving effective homeopathic therapeutics for treating Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5-15 years. By analyzing clinical cases, the study seeks to identify reliable indications for specific homeopathic remedies that reduce ADHD symptom severity, as measured by the Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) over six months. The research involves detailed case-taking, individualized remedy selection, and regular follow-up, with outcomes assessed through standardized rating scales. The study addresses the need for safe, alternative treatments for ADHD and aims to contribute evidence on the role of homeopathy in pediatric mental health management.

 
Close